Zurich Cantonal Bank
ALT icon

Zurich Cantonal Bank’s Altimmune ALT Stock Holding History

Zurich Cantonal Bank’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,125
Closed -$4.9K – 2580
2025
Q3 		$4.24K Sell
1,125
-487
-30% -$1.88K ﹤0.01% 2518
2025
Q2 		$6.24K Sell
1,612
-14,868
-90% -$80.5K ﹤0.01% 2531
2025
Q1 		$82.4K Buy
16,480
+1,792
+12% +$11.4K ﹤0.01% 2445
2024
Q4 		$106K Hold
14,688
– – ﹤0.01% 2411
2024
Q3 		$90.2K Hold
14,688
– – ﹤0.01% 2455
2024
Q2 		$97.7K Buy
14,688
+9,635
+191% +$71.1K ﹤0.01% 2382
2024
Q1 		$51.4K Buy
5,053
+4,911
+3,458% +$50K ﹤0.01% 2560
2023
Q4 		$1.6K Sell
142
-934
-87% -$3.9K ﹤0.01% 2691
2023
Q3 		$2.8K Sell
1,076
-172
-14% -$493 ﹤0.01% 2766
2023
Q2 		$4.41K Sell
1,248
-10,904
-90% -$49K ﹤0.01% 2764
2023
Q1 		$51.3K Buy
12,152
+1,506
+14% +$17.9K ﹤0.01% 2589
2022
Q4 		$175K Buy
+10,646
New +$120K ﹤0.01% 1900

Other funds holding ALT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Zurich Cantonal Bank's ALT Position: Q4 2025 in Review

Zurich Cantonal Bank sold out of Altimmune (ALT) in Q4 2025, closing a stake of 1,125 shares — an estimated $4.9K sold.

Zurich Cantonal Bank first reported a position in ALT in Q4 2022 and held it in 12 quarters. The position peaked at $175K in Q4 2022. 181 funds tracked by Wall St. Rank hold ALT as of Q4 2025.

  • Zurich Cantonal Bank reported no remaining Altimmune position as of Q4 2025 after selling out during the quarter.
  • Zurich Cantonal Bank sold 1,125 Altimmune shares in Q4 2025, an estimated $4.9K.
  • Zurich Cantonal Bank first reported a position in Altimmune in Q4 2022 and held it in 12 quarters.
  • Zurich Cantonal Bank's Altimmune position peaked at $175K in Q4 2022.
  • 181 funds tracked by Wall St. Rank held Altimmune as of Q4 2025.

Based on Zurich Cantonal Bank's 13F filing for Q4 2025, filed 27 Jan 2026.